In Brief:
Hyperreflective retinal spots visible on spectral-domain optical coherence tomography with specific characteristics, such as size, location, absence of back shadowing, and intensity of hyperreflectivity, may become a new biomarker of retinal inflammation in diabetic patients with and without macular edema.